THIS IS A PUBLIC ANNOUNCEMENT FOR INFORMATION PURPOSES ONLY AND IS NOT A PROSPECTUS ANNOUNCEMENT. THIS DOES NOT CONSTITUTE AN INVITATION OR OFFER TO ACQUIRE, PURCHASE OR SUBSCRIBE TO SECURITIES.

TECHNOCRATS PLASMA SYSTEMS LIMITED

(Formerly Known as Technocrats Plasma Systems Private Limited)

Corporate Identity Numbers: U28299MH1994PLC082603

Our Company was incorporated on November 01, 1994 as 'Technocrat Plasma Systems Private Limited', a private limited company under the provisions of the Companies Act, 1956, pursuant to a certificate of incorporation issued by the Registrar of Companies, Maharashtra, at Mumbai. Subsequently, the name of our Company was changed to "Technocrats Plasma Systems Private Limited" pursuant to a resolution passed in the extra Ordinary General Meeting held on the date October 24, 2021 and a fresh certificate of Incorporation for name change issued by the Registrar of Companies, Mumbai on September 16, 2021. Our Company was converted into a public company pursuant to a resolution passed by our Board of Directors in their meeting held on September 22, 2025 and by our Shareholders in an Annual General Meeting held on September 25, 2025 and consequently the name of our Company was changed to "Technocrats Plasma Systems Limited" and a fresh certificate of incorporation dated October 29, 2025, consequent upon conversion to public company was issued by the Central Registration Centre on behalf of the jurisdictional Registrar of Companies. Pursuant to a special resolution passed by the shareholders of our Company at the Extra-Ordinary General Meeting held on May 23, 2026, the Object Clause of the Memorandum of Association of our Company was altered. Consequent thereto, a fresh Certificate of Registration of the Special Resolution confirming the alteration of the Object Clause(s), dated June 1, 2026. The Corporate Identification Number (CIN) of our Company is U28299MH1994PLC082603.

1. Substantial portion of our revenue from operations is from our top 10 customers (which accounted for 62.61%, 83.89% and 55.70% of our total revenue from operations for the Fiscal Year ended March 31, 2026, March 31, 2025 and March 31, 2024). Loss of any such customers or reduction in business or demand from such customers will have a significant adverse impact on our business and results of operation.

2. We are dependent upon few suppliers for the material requirements of our business. Further, we do not have definitive agreements or fixed terms of trade with most of our suppliers. Failure to successfully leverage our relationships with existing suppliers or to identify new suppliers could adversely affect our business operations.

3. Any disruptions to the supply, or increases in the pricing, of the raw materials and finished products that we procure, may adversely affect the supply and pricing of our products and, in turn, adversely affect our business, cash flows, financial condition and results of operations.

4. Our revenues are significantly dependent on certain geographical regions, and any adverse developments in these regions could adversely impact our business, financial condition and results of operations.

5. Our success is dependent on our relationship with our customers, and we do not, generally enter into long term purchase contracts. This exposes us to risk emanating from the inability to retain our established customers as our clients.

6. If we are unable to effectively manage or expand our sales and service network or pursue our growth strategy, our business prospects, financial condition, and results of operations may be adversely affected.

7. We require certain approvals, licenses and permits for our operations, and failure to obtain or renew them in a timely manner may adversely affect our business.

8. Our manufacturing operations are concentrated in Maharashtra, exposing us to regional and local risks. Any significant disruption in this region could materially and adversely affect our manufacturing operations, business, financial condition, results of operations and cash flows.

9. Our Statutory Auditor have included certain qualifications in the Annexure to the Auditor's Report for financial statements pertaining to F.Y. 2022-23

10. Our net cash flows have been negative in some years in the past. Any negative cash flow in the future may affect our liquidity and financial condition.

This Issue was made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR") read with Regulation 229 of the SEBI ICDR Regulations and in compliance with Regulation 253 of the SEBI ICDR Regulations, wherein not more than 50.00% of the Net Issue was made available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBs") (the "QIB Portion") our Company in consultation with the BRLM may allocated 60.00% of the QIB Portion to Anchor Investors on a discretionary basis ("Anchor Investor Portion"). 33.33% of the Anchor Investor Portion shall be reserved for domestic Mutual Funds and 6.67% for Life Insurance Companies and Pension Funds (aggregating to 40%), subject to valid Bids being received from them at or above the Anchor Investor Allocation Price in accordance with the SEBI ICDR Regulations. In the event of under-subscription in the Life Insurance Companies and Pension Funds portion, the same may be allocated to domestic Mutual Funds. Further, 5.00% of the Net QIB Portion was made available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the Net QIB Portion was made available for allocation on a proportionate basis to all QIB Bidders, including Mutual Funds, subject to valid Bids having been received at or above the Issue Price. However, if the aggregate demand from Mutual Funds is less than 5.00% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion were added to the remaining Net QIB Portion for proportionate allocation to QIBs. Further, not less than 15.00% of the Net Issue was made available for allocation on a proportionate basis to Non-Institutional Investors out of which (a) one third of the portion available to non-institutional investors was reserved for applicants with application size of more than two lots and up to such lots equivalent to not more than Rs. 10 lakhs (b) two third of the portion available to non-institutional investors was reserved for applicants with application size of more than Rs. 10 lakhs, provided that the unsubscribed portion in either of the sub-categories specified in clauses (a) or (b) was allocated to applicants in the other sub-category of non-institutional investors, and not less than 35.00% of the Net Issue was made available for allocation to the Individual Investors in accordance with the SEBI ICDR Regulations, subject to valid Bids having been received from them at or above the Issue Price. All Bidders were required to participate in the Issue by mandatorily utilizing the Application Supported by Blocked Amount ("ASBA") process by providing details of their respective ASBA Account (as defined hereinafter) in which the corresponding Bid Amounts were blocked by the Self Certified Syndicate Banks ("SCSBs") or under the UPI Mechanism, as the case may be, to the extent of respective Bid Amounts. For details, see "Issue Procedure" on page 359 of this Prospectus.

The bidding for Anchor investors was opened and closed on August 13, 2026. The company received 9 Anchor Investors application for 13,14,000 Equity Shares. The Anchor Investor Allocation Price was finalized at Rs. 132.00 per Equity Share. A total of 13,14,000 Equity Shares were allotted under the Anchor Investor portion aggregating to 17,34,48,000.

The issue (excluding Anchor Investor Portion) received 168460 applications for Equity Shares (after rejections and after removing Multiple/Duplicate bids, and Bid not Banked) resulting in 188.85 times subscription (including reserved portion of market maker). The Details of the total Applications received in the issue from various categories are as under (after rejections):

* Individual Investors means Individual Investors who applies for minimum application size.

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange - BSE on August 19, 2026

1. Allocation to Individual Investor (After Rejections & Withdrawal) (including ASBA Applications) The Basis of Allotment to the Individual Investors, who have bid at or above the Issue Price of Rs. 132 per equity shares, was finalized in consultation with BSE. The category was subscribed by 175.80 times i.e. for 27,03,88,000 Equity Shares. Total number of shares allotted in this category is 15,38,000 Equity Shares to 769 successful applicants. The category wise details of the Basis of Allotment as under:

2. Allocation to Non-Institutional Investors (up to Rs. 10 lakhs) (After Rejections & Withdrawal): The Basis of Allotment to Other than Individual Investors (who applied for minimum application size), who have bid at Issue Price of Rs. 132 per equity shares or above, was finalized in consultation with BSE. The category was subscribed by 188.11 times i.e. for 4,13,84,000 Equity Shares. The total number of shares allotted in this category is 2,20,000 Equity Shares to 73 successful applicants. The category wise details of the Basis of Allotment are as under:

3. Allocation to Non-Institutional Investors (above Rs. 10 lakhs) (After Rejections & Withdrawal) (including ASBA Applications)

The Basis of Allotment to Other than Individual Investors (who applied for minimum application size), who have bid at Issue Price of Rs. 132 per equity shares or above, was finalized in consultation with BSE. The category was subscribed by 379.16 times i.e. 16,68,32,000 for Equity Shares. The total number of shares allotted in this category is 4,40,000 Equity Shares to 146 successful applicants. The category wise details of the Basis of Allotment are as under:

Note 1: 2 applicants to be allotted 3000 shares amongst from Sr. no 4 to 45 Note 2: 2 Lots of 1000 shares to be allotted amongst 146 allottees

3. Allocation to QIBs excluding Anchor Investors (After Rejections & Withdrawal): The Basis of Allotment to QIBs, who have bid at Issue Price of 132/- per Equity Shares or above, was finalized in consultation with BSE. The category was subscribed by 174.62 times i.e. for 14,55,03,000 Equity shares. The total number of shares allotted in this category is 8,77,000 Equity Shares to 86 successful applicants. The category wise details of the Basis of Allotment are as under:

4. Allocation to Anchor Investors (After Rejections & Withdrawal): The Company in consultation with the BRLM has allotted 13,14,000 Equity Shares to 9 Anchor Investors at Anchor Investor Issue Price of Rs. 132/- per Equity Shares in accordance with the SEBI ICDR Regulations. The category wise details of the Basis of Allotment are as under:

5. Allocation to Market Maker (After Rejections & Withdrawal): The Basis of Allotment to Market Maker who have bid at Issue Price of Rs. 132/- per Equity Shares or above, was finalized in consultation with BSE. The category was subscribed by 1.00 times i.e. for 2,31,000 Equity shares. The total number of shares allotted in this category is 2,31,000 Equity Shares. The category wise details of the Basis of Allotment are as under:

The Board of Directors of the Company on August 19, 2026, has taken on record the Basis of Allotment of Equity Shares as approved by BSE Limited and has allotted the Equity Shares to various successful bidders. The Allotment Advices-cum-Intimations and/or notices have been forwarded to the email ids and/or address of the Applicants as registered with the depositories/as filled in the application form. Further, the instructions to Self-Certified Syndicate Banks for unblocking the funds & transfer to Public Issue Account have been issued on or before August 20, 2026 and payment to non-syndicate brokers has been issued on or before August 20, 2026. In case the same is not received within two working days, investors may contact at the address given below. The equity shares allotted to the successful allottees have been uploaded on August 20, 2026 for credit into the respective beneficiary accounts subject to validation of the account details with the depositories concerned. The Company will file the Listing application with BSE Limited on or before August 20, 2026. The Company has received the listing and trading approval from BSE Limited and trading will commence on August 21, 2026.

The details of the allotment made would also be hosted on the website of the Registrar to the issue, Maashitla Securities Private Limited SEBI Registration Number INR000004370 at, All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicants, serial number of the Bid cum Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:

	MAASHITLA SECURITIES PRIVATE LIMITED
	SEBI Registration Number: INR000004370
	Address: 451, Krishna Apra Business Square, Netaji Subhash Place, Pitampura, New Delhi - 110034
	Tel. Number: 011-47581432, Email Id: ipo@maashitla.com
	Investors Grievance Id: investor.ipo@maashitla.com; Website: www.maashitla.com
	Contact Person: Mr. Mukul Agrawal; CIN: U67100DL2010PTC208725

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF TECHNOCRATS PLASMA SYSTEMS LIMITED.

Technocrats Plasma Systems Limited is proposing, subject to market conditions, applicable receipt of issue of its equity shares and had filed the Prospectus with the Registrar of Companies, Mumbai. The Prospectus is available on the website of SEBI at www.sebi.gov.in, the website of the Book Running Lead Manager at www.rarever.in, website of the BSE at www.bseindia.com and website of Issuer Company at www.technocratplasma.com ; Investors should note that investment in Equity Shares involves a high degree of risk and for details, Investors should refer to and rely on the Prospectus including the section titled "Risk Factors" beginning on page 23 of the Prospectus which has been filed with ROC. The Equity Shares have not and will not be registered under the US Securities Act (the "Securities Act") or any state securities law in United States and may not be Issued or sold within the United States or to, or for the account or benefit of, "U.S. persons" (as defined in the Regulation S under the Securities Act), except pursuant to an exemption from, or in a transaction not subject to the registration requirements of the Securities Act of 1933.